Analysis of spontaneous and bleomycin-induced chromosome damage in peripheral lymphocytes of long-haul aircrew members from Argentina

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 639, Issue 1-2, 2008, Pages 64-79

  Bolzán, Alejandro D ^a,c   Bianchi, Martha S ^a,c   Giménez, Esteban M ^a   Flaqué, María C Díaz ^a   Ciancio, Vicente R ^b  

^a Instituto Multidisciplinario de Biologia Celular   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Aircrew; Bleomycin; Bleomycin assay; Chromosome damage; Mutagen sensitivity assay

Indexed keywords

BLEOMYCIN;

ADULT; AGED; AIRPLANE CREW; ARGENTINA; ARTICLE; CHROMOSOME DAMAGE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; COSMIC RADIATION; DRINKING BEHAVIOR; FEMALE; HUMAN; IN VITRO STUDY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PERIPHERAL LYMPHOCYTE; POPULATION; PRIORITY JOURNAL; RING CHROMOSOME; SMOKING HABIT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AIRCRAFT; ARGENTINA; BLEOMYCIN; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DNA DAMAGE; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RADIATION, IONIZING; TIME FACTORS;

EID: 39249084074     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.11.003     Document Type: Article

References (67)

1. Bramlitt E.T. Commercial aviation crewmember radiation doses. Health Phys. 49 (1985) 945-948
2. Friedberg W., Faulkner D.N., Snyder L., Darden Jr. E.B., and O'Brien K. Galactic cosmic radiation exposure and associated health risks for air carrier crewmembers. Aviat. Space Environ. Med. 60 (1989) 1104-1108
3. Friedberg W., Duke F.E., Snyder L., Faultner D.N., O'Brien K., Darden Jr. E.B., and Parker D.E. The cosmic radiation environment at air carrier flights altitude and possible associated health risks. Radiat. Prot. Dosim. 48 (1993) 21-25
4. Bagshaw M., Irving D., and Davies D.M. Exposure to cosmic radiation of British Airways flying crew on ultralonghaul routes. Occup. Environ. Med. 53 (1996) 495-498
5. Lim M.K. Cosmic rays. Are air crew at risk?. Occup. Environ. Med. 59 (2002) 428-432
6. Bartlett D.T. Radiation protection aspects of the cosmic radiation exposure of aircraft crew. Radiat. Prot. Dosim. 109 (2004) 349-355
7. A.J. Sigurdson, E. Ron, Cosmic Radiation Exposure and Cancer Risk Among Flight Crew, Cancer Invest. 22 (2004) 743-761.
8. Reitz G. Radiation environment in the stratosphere. Radiat. Prot. Dosim. 48 (1993) 5-20
9. Bottollier-Depois J.-F., Chau Q., Bouisset P., Kerlau G., Plawinski L., and Lebaron-Jacobs L. Assessing exposure to cosmic radiation during long-haul flights. Radiat. Res. 153 (2000) 526-532
10. Goldhagen P. Overview of aircraft radiation exposure and recent ER-2 measurements. Health Phys. 79 (2000) 526-544
11. Wilson J.W. Overview of radiation environments and human exposures. Health Phys. 79 (2000) 470-494
12. International Commission on Radiological Protection (ICRP). 1990 Recommendations of the International Commission on Radiological Protection, Pergamon Press, Oxford, United Kingdom, 1991, Publication no. 60.
13. Lewis B.J., Bennett L.G., Green A.R., McCall M.J., Ellaschuk B., Butler A., and Pierre M. Galactic and solar radiation exposure to aircrew during a solar cycle. Radiat. Prot. Dosim. 102 (2002) 207-227
14. Grayson J.K., and Lyons T.J. Brain cancer, flying, and socioeconomic status: a nested case-control study of USAF aircrew. Aviat. Space Environ. Med. 67 (1996) 1152-1154
15. Rafnsson V., Tulinius H., Jonasson J.G., and Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control. 12 (2001) 95-101
16. Pukkala E., Aspholm R., Auvinen A., Eliasch H., Gundestrup M., Haldorsen T., Hammar N., Hrafnkelsson J., Kyyronen P., Linnersjo A., Rafnsson V., Storm H., and Tveten U. Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ 325 (2002) 567-572
17. Zeeb H., Blettner M., Langner I., Hammer G.P., Ballard T.J., Santaquilani M., Gundestrup M., Storm H., Haldorsen T., Tveten U., Hammar N., Linnersjö A., Velonakis E., Tzonou A., Auvinen A., Pukkala E., Rafnsson V., and Hrafnkelsson J. Mortality from cancer and other causes among airline cabin attendants in Europe: a collaborative cohort study in eight countries. Am. J. Epidemiol. 158 (2003) 35-46
18. Norppa H., Bonassi S., Hansteen I.L., Hagmar L., Stromberg U., Rossner P., Boffetta P., Lindholm C., Gundy S., Lazutka J., Cebulska-Wasilewska A., Fabianova E., Sram R.J., Knudsen L.E., Barale R., and Fucic A. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res. 600 (2006) 37-45
19. Perera F.P. Environment and cancer: who are susceptible?. Science 278 (1997) 1068-1073
20. Au W.W. Mutagen sensitivity assays in population studies. Mutat. Res. 544 (2003) 273-277
21. Hsu T.C., Johnston D.A., Cherry L.M., Ramkissoon D., Schantz S.P., Jessup J.M., Winn R.J., Shirley L., and Furlong C. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer 43 (1989) 403-409
22. Wu X., Zheng Y.-L., and Hsu T.C. Mutagen-induced chromatid breakage as a marker of cancer risk. Methods Mol. Biol. 291 (2005) 59-67
23. Wu X., Gu J., and Spitz M.R. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res. 67 (2007) 3493-3495
24. Povirk L.F., and Austin M.J. Genotoxicity of bleomycin. Mutat. Res. 257 (1991) 127-143
25. Cloos J., Spitz M.R., Schantz S.P., Hsu T.C., Zhang Z.F., Tobi H., Braakhuis B.J., and Snow G.B. Genetic susceptibility to head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 88 (1996) 530-535
26. Cloos J., Nieuwenhuis E.J., Boomsma D.I., Kuik D.J., van der Sterre M.L., Arwert F., Snow G.B., and Braakhuis B.J. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J. Natl. Cancer Inst. 91 (1999) 1125-1130
27. Aben K.K., Cloos J., Koper N.P., Braakhuis B.J., Witjes J.A., and Kiemeney L.A. Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma. Int. J. Cancer 88 (2000) 493-496
28. Hsu T.C., Spitz M.R., and Schantz S.P. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1 (1991) 83-89
29. Olivieri G., Bodycote J., and Wolff S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science 223 (1984) 594-597
30. Shadley J.D., and Wolff S. Very low doses of X-rays can cause human lymphocytes to become less susceptible to ionizing radiation. Mutagenesis 2 (1987) 95-96
31. Wang Z.Q., Saigusa S., and Sasaki M.S. Adaptive response to chromosome damage in cultured human lymphocytes primed with low doses of X-rays. Mutat. Res. 246 (1991) 179-186
32. Wolff S. The adaptive response in radiobiology: evolving insights and implications. Environ. Health Perspect. 106 (1998) 277-283
33. Wolff S., Afzal V., Wiencke J.K., Olivieri G., and Michaeli A. Human lymphocytes exposed to low doses of ionizing radiations become refractory to high doses of radiation as well as to chemical mutagens that induce double-strand breaks in DNA. Int. J. Radiat. Biol. 53 (1988) 39-47
34. Tedeschi B., Caporossi D., Vernole P., Padovani L., Appolloni M., Anzidei P., and Mauro F. Do human lymphocytes exposed to the fallout of the Chernobyl accident exhibit an adaptive response? 2. Challenge with bleomycin. Mutat. Res. 332 (1995) 39-44
35. Barquinero J.F., Barrios L., Caballin M.R., Miró R., Ribas M., Subias A., and Egozcue J. Decreased sensitivity to the cytogenetic effects of bleomycin in individuals occupationally exposed to ionizing radiation. Mutat. Res. 354 (1996) 81-86
36. Stephan G., and Pressl S. Chromosomal aberrations in peripheral lymphocytes from healthy subjects as detected in first cell division. Mutat. Res. 446 (1999) 231-237
37. Perry P.E., and Wolff P. New Giemsa method for the differential staining of sister chromatids. Nature 251 (1974) 156-158
38. Musilova J., Michalova K., Folberova L., Neradilova M., and Abrahamova J. Chromosome sensitivity to bleomycin in patients with dominantly inherited and sporadic tumors. Neoplasma 40 (1993) 93-96
39. Szekely G., Remenar E., Kasler M., and Gundy S. Does the bleomycin sensitivity assay express cancer phenotype?. Mutagenesis 18 (2003) 59-63
40. Tzancheva M., and Komitowski D. Latent chromosomal instability in cancer patients. Hum. Genet. 99 (1997) 47-51
41. Michalska J., Motykiewicz G., Kalinowska E., and Chorazy M. Bleomycin sensitivity test in the exposed and reference human populations. Mutat. Res. 418 (1998) 43-48
42. Bolzán A.D., Bianchi N.O., Larramendy M.L., and Bianchi M.S. Chromosomal sensitivity of human lymphocytes to bleomycin. Influence of antioxidant enzyme activities in whole blood and different blood fractions. Cancer Genet. Cytogenet. 64 (1992) 133-138
43. Scheid W., Weber J., Traut H., and Gabriel H.W. Chromosome aberrations induced in the lymphocytes of pilots and stewardesses. Naturwissenschaften 80 (1993) 528-530
44. Heimers A., Schröder H., Lengfelder E., and Schmitz-Feuerhake I. Chromosome aberration analysis in aircrew members. Radiat. Prot. Dosim. 60 (1995) 171-175
45. Romano E., Ferrucci L., Nicolai F., Derme V., and De Stefano G.F. Increase of chromosomal aberrations induced by ionizing radiation in peripheral blood lymphocytes of civil aviation pilots and crew members. Mutat. Res. 377 (1997) 89-93
46. Zwingmann I.H., Welle I.J., van Herwijnen M., Engelen J.J., Schilderman P.A., Smid T., and Kleinjans J.C. Oxidative DNA damage and cytogenetic effects in flight engineers exposed to cosmic radiation. Environ. Mol. Mutagen. 32 (1998) 121-129
47. Wolf G., Pieper R., and Obe G. Chromosomal alterations in peripheral lymphocytes of female cabin attendants. Int. J. Radiat. Biol. 75 (1999) 829-836
48. Heimers A. Chromosome aberration analysis in Concorde pilots. Mutat. Res. 467 (2000) 169-176
49. Picco S.J., De Luca J.C., Mac Intyre C., and Dulout F.N. Chromosomal damage in air crew members of international flights. A preliminary report. Genet. Mol. Biol. 23 (2000) 1117-1120
50. Cavallo D., Marinaccio A., Perniconi B., Tomao P., Pecoriello V., Moccaldi R., and Iavicoli S. Chromosomal aberrations in long-haul air crew members. Mutat. Res. 513 (2002) 11-15
51. Nicholas J.S., Butler G.C., Davis S., Bryant E., Hoel D.G., and Mohr Jr. L.C. Stable chromosome aberrations and ionizing radiation in airline pilots. Aviat. Space Environ. Med. 74 (2003) 953-956
52. Natarajan T.G., Ganesan N., Carter-Nolan P., Tucker C.A., Shields P.G., and Adams-Campbell L.L. Gamma-radiation-induced chromosomal mutagen sensitivity is associated with breast cancer risk in African-American women: caffeine modulates the outcome of mutagen sensitivity assay. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 437-442
53. Lee J.J., Trizna Z., Hsu T.C., Spitz M.R., and Hong W.K. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 191-197
54. Wu X., Gu J., Amos C.I., Jiang H., Hong W.K., and Spitz M.R. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer 83 (1998) 1118-1127
55. Savage J.R.K. Sites of radiation induced chromosome exchanges. Curr. Top. Radiat. Res. 6 (1970) 129-194
56. Kihlman B.A., and Andersson H.C. Synergistic enhancement of the frequency of chromatid aberrations in cultured human lymphocytes by combinations of inhibitors of DNA repair. Mutat. Res. 150 (1985) 313-325
57. Hagmar L., Bonassi S., Strömberg U., Brøgger A., Knudsen L.E., Norppa H., and Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: a report of the European Study Group on Cytogenetics Biomarkers and Health (ESCH). Cancer Res. 58 (1998) 4117-4121
58. Terzoudi G.I., and Pantelias G.E. Cytogenetic methods for biodosimetry and risk individualisation after exposure to ionising radiation. Radiat. Prot. Dosim. 122 (2006) 513-520
59. Bender M.A., Awa A.A., Brooks A.L., Evans H.J., Groer P.G., Littlefield L.G., Pereira C., Preston R.J., and Wachholz B.W. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat. Res. 196 (1988) 103-159
60. Scott D., Barber J.B., Spreadborough A.R., Burrill W., and Roberts S.A. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int. J. Radiat. Biol. 75 (1999) 1-10
61. Takata M., Sasaki M.S., Sonoda E., Morrison C., Hashimoto M., Utsumi H., Yamaguchi-Iwai Y., Shinohara A., and Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17 (1998) 5497-5508
62. Johnson R.D., and Jasin M. Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells. EMBO J. 19 (2000) 3398-3407
63. Christmann M., Tomicic M.T., Roos W.P., and Kaina B. Mechanisms of human DNA repair: an update. Toxicology 193 (2003) 3-34
64. Adema A.D., Cloos J., Verheijen R.H., Braakhuis B.J., and Bryant P.E. Comparison of bleomycin and radiation in the G2 assay of chromatid breaks. Int. J. Radiat. Biol. 79 (2003) 655-661
65. Shin D.S., Chahwan C., Huffman J.L., and Tainer J.A. Structure and function of the double-strand break repair machinery. DNA Repair 3 (2004) 863-873
66. Dresp J., Schmid E., and Bauchinger M. The cytogenetic effect of bleomycin on human peripheral lymphocytes in vitro and in vivo. Mutat. Res. 56 (1978) 341-353
67. Dutta A., Chakraborty A., Saha A., Ray S., and Chatterjee A. Interaction of radiation- and bleomycin-induced lesions and influence of glutathione level on the interaction. Mutagenesis 20 (2005) 329-335